Glaucoma medical treatment as a predictor of XEN45 subconjunctival gel implant hypotensive efficacy. Mendez-Hernandez C, Palomino-Bautista C, Torres-Imaz R, Pena-Urbina P, et al. Graefes Arch Clin Exp Ophthalmol 2022 Aug 20. pii: 10.1007/s00417-022-05810.

Read + Share

Amedeo Smart

Independent Medical Education

Mendez-Hernandez C, Palomino-Bautista C, Torres-Imaz R, Pena-Urbina P, et al. Glaucoma medical treatment as a predictor of XEN45 subconjunctival gel implant hypotensive efficacy. Graefes Arch Clin Exp Ophthalmol 2022 Aug 20. pii: 10.1007/s00417-022-05810.
PMID: 35986778